Cargando…
Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity
The extraordinary variability of HIV-1 poses a major obstacle to vaccine development. The effectiveness of a vaccine is likely to vary dramatically in different populations infected with different HIV-1 subtypes, unless innovative vaccine immunogens are developed to protect against the range of HIV-...
Autores principales: | Tongo, Marcel, Burgers, Wendy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213573/ https://www.ncbi.nlm.nih.gov/pubmed/25341662 http://dx.doi.org/10.3390/v6103968 |
Ejemplares similares
-
Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
por: Tongo, Marcel, et al.
Publicado: (2013) -
The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012) -
P16-44. Investigating T cell immune responses in Cameroon, a country with broad HIV-1 genetic diversity
por: Tongo, M, et al.
Publicado: (2009) -
Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country
por: Tongo, Marcel, et al.
Publicado: (2015) -
Genetic characterization of HIV-1 subtype G envelope sequences by single genome analysis
por: Rene Ghislain, E, et al.
Publicado: (2012)